AI Visibility Scorecard
avertdtest.com · Healthcare
Somewhat visible. AI bots can read AvertD - Stop Opioid Addiction Before It Starts, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 4 times
Claude · Meta AI
#188,841 of 923,184 in Healthcare for AI visibility
5
AEO Visibility
iBorderline · 5.4/10
35
Muse Index Score
iAI agent readiness
Agent-ready · 35/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
AvertD is a business whose own site puts it this way: "AvertD is a clinically validated genetic test that identifies an individual’s genetic risk for developing Opioid Use Disorder (OUD)." To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.4 out of 10, readable in places and missing in others.
Our crawl found structured data on the page (BreadcrumbList, Organization, WebPage), a sitemap and a readable heading structure. It is missing an llms.txt file.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
Strong · Good · Fair · Weak
Structured Data
Good
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Strong
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.4/10, AvertD - Stop Opioid Addiction Before It Starts has a working base to build on - fixable, and the signals above are where to start.
Who Has an Elevated Genetic Risk for Opioid Use Disorder?
Although opioids may be of benefit in the treatment of pain when used as prescribed, the use of opioids may lead to dependence, misuse, and addiction in some people. A combination of several poorly understood factors (including genetic and non-genetic factors) may contribute to opioid misuse and abuse.
Is this your brand?
The exact fixes for AvertD - Stop Opioid Addiction Before It Starts
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for AvertD - Stop Opioid Addiction Before It Starts.
Scored by Engagemii on August 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/avertdtest
Cite this score: Engagemii (2026). "AEO Score for AvertD - Stop Opioid Addiction Before It Starts." Retrieved from https://engagemii.com/aeo/brands/avertdtest
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform